Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cameron

Showing results (1591-1600 of 1,688) with videos related to

Pageof 169
Sort By:
JAMA|October 26, 2018
Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical TrialD James Cooper, Alistair D Nichol, Michael Bailey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancerG N Hortobagyi, S M Stemmer, H A Burris, et al.
Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.
BMJ (Clinical Research Ed.)|January 9, 2025
Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trialElissa M Ozanne, Geoffrey D Barnes, Juan P Brito, et al.
Journal of Cardiac Failure|March 14, 2013
The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and designRajalakshmi Santhanakrishnan, Tze P Ng, Vicky A Cameron, et al.
Breast (Edinburgh, Scotland)|June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidenceRodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but AlsoJohn M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
Emergency Medicine Australasia : EMA|December 14, 2020
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4)Gerard M O'Reilly, Robert D Mitchell, Biswadev Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
The New Zealand Medical Journal|August 18, 2018
Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New ZealandStephen P Robertson, Jennie Harre Hindmarsh, Sarah Berry, et al.
Pageof 169

Showing results (1591-1600 of 1,688) with videos related to

Sort By:
Pageof 169
JAMA|October 26, 2018
Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical TrialD James Cooper, Alistair D Nichol, Michael Bailey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancerG N Hortobagyi, S M Stemmer, H A Burris, et al.
Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.
BMJ (Clinical Research Ed.)|January 9, 2025
Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trialElissa M Ozanne, Geoffrey D Barnes, Juan P Brito, et al.
Journal of Cardiac Failure|March 14, 2013
The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and designRajalakshmi Santhanakrishnan, Tze P Ng, Vicky A Cameron, et al.
Breast (Edinburgh, Scotland)|June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidenceRodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but AlsoJohn M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
Emergency Medicine Australasia : EMA|December 14, 2020
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4)Gerard M O'Reilly, Robert D Mitchell, Biswadev Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
The New Zealand Medical Journal|August 18, 2018
Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New ZealandStephen P Robertson, Jennie Harre Hindmarsh, Sarah Berry, et al.
Pageof 169